Skip to content

VYANT BIO, INC

CIK 0001349929

← back to feed
Revenue (TTM)
$876K
−42.0% YoY FY Mar 2023
Net Income (TTM)
−$22.89M
+44.5% YoY FY Mar 2023
EPS Diluted (TTM)
−$0.75
+49.0% YoY FY Mar 2023
Gross Margin
359.6%
FY Mar 2023
Operating Margin
-1,791.1%
FY Mar 2023
Net Margin
-2,613.2%
FY Mar 2023
Free Cash Flow (TTM)
−$14.63M
FY Mar 2023
Cash
$10.04M
FY Mar 2023
Total Debt
$57K
FY Mar 2023
Shares Outstanding
6.27M sh
FY Mar 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings